2-[2-(4-Carbamimidoyl-benzenesulfonylamino)-acetylamino]-3-(4-carbamimidoyl-phenyl)-propionic acid

ID: ALA341933

PubChem CID: 10095093

Max Phase: Preclinical

Molecular Formula: C19H22N6O5S

Molecular Weight: 446.49

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)c1ccc(CC(NC(=O)CNS(=O)(=O)c2ccc(C(=N)N)cc2)C(=O)O)cc1

Standard InChI:  InChI=1S/C19H22N6O5S/c20-17(21)12-3-1-11(2-4-12)9-15(19(27)28)25-16(26)10-24-31(29,30)14-7-5-13(6-8-14)18(22)23/h1-8,15,24H,9-10H2,(H3,20,21)(H3,22,23)(H,25,26)(H,27,28)

Standard InChI Key:  MREBMJAXNFLJHN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 31 32  0  0  0  0  0  0  0  0999 V2000
    6.7167   -0.6875    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.2792   -0.2667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9667    0.9750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6375    2.4708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4542   -2.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1042    1.5583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4042    0.5583    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1500   -1.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2625   -0.0292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7000   -0.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5750   -1.2792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.2917   -0.5167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0167   -1.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0750    2.0583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6542    3.0708    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0375   -2.1667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3875    0.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6667    1.9750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6792   -0.2000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0042   -1.6875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7167   -0.9292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1542   -1.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4500   -2.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9292    1.4625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6542    2.2333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3250   -2.9292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1000    2.1875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9500    1.2208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6875    1.7333    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3667    1.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0917    1.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  7  1  0
  4 14  1  0
  5 13  1  0
  6  3  1  0
  7  9  1  0
  8  1  1  0
  9 10  1  0
 10  2  1  0
 11  1  2  0
 12  1  2  0
 13 22  1  0
 14 25  2  0
 15  4  2  0
 16  5  2  0
 17  3  1  0
 18  6  2  0
 19  9  2  0
 20  8  2  0
 21  8  1  0
 22 21  2  0
 23 20  1  0
 24 30  2  0
 25 31  1  0
 26  5  1  0
 27  4  1  0
 28 17  1  0
 29  6  1  0
 30 28  1  0
 31 28  2  0
 13 23  2  0
 14 24  1  0
M  END

Associated Targets(Human)

F10 Tclin Coagulation factor X (9693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PROC Tchem Vitamin K-dependent protein C (491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KLKB1 Tclin Plasma kallikrein (2047 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLG Tclin Plasminogen (2339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLAU Tchem Urokinase-type plasminogen activator (2016 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TPSG1 Tchem Tryptase gamma (16 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

F10 Coagulation factor X (201 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F2 Thrombin (1630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypsin II (226 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 446.49Molecular Weight (Monoisotopic): 446.1372AlogP: -0.65#Rotatable Bonds: 10
Polar Surface Area: 212.31Molecular Species: ZWITTERIONHBA: 6HBD: 7
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 9#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.12CX Basic pKa: 11.60CX LogP: -3.45CX LogD: -4.73
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.18Np Likeness Score: -0.62

References

1. Gabriel B, Stubbs MT, Bergner A, Hauptmann J, Bode W, Stürzebecher J, Moroder L..  (1998)  Design of benzamidine-type inhibitors of factor Xa.,  41  (22): [PMID:9784099] [10.1021/jm980227t]

Source